Browse > Article

Activity Change of Sphingomyelin Catabolic Enzymes during Dimethylnitrosamine-induced Hepatic Fibrosis in Rats  

Sacket, Santosh J. (Laboratory of Pharmacology, College of Pharmacy (BK21 Project) and Longevity Life Science and Technology Institutes, Pusan National University)
Im, Dong-Soon (Laboratory of Pharmacology, College of Pharmacy (BK21 Project) and Longevity Life Science and Technology Institutes, Pusan National University)
Publication Information
Biomolecules & Therapeutics / v.16, no.1, 2008 , pp. 34-39 More about this Journal
Oxidative stress may represent a common link between chronic liver damage and hepatic fibrosis. In the present study, we investigated activity changes of sphingomyelin catabolic enzymes, such as sphingomyelinases and ceramidases by using dimethylnitrosamine (DMN)-treated Sprague-Dawley (SD) male rats hepatic fibrosis model as a hepatic fibrosis model. Twenty rats divided into five groups received: (1) saline; (2) DMN for 1 week, (3) DMN for 2 weeks, (4) DMN for 3 weeks, and (5) DMN for 4 weeks by intraperitoneally 10 mg/kg of body weight for three consecutive days a week. Activities of acidic and neutral sphingomyelinases and acidic, neutral and alkaline ceramidases were measured in the liver and kidney from DMN-treated rats. We found increased ceramidase activities from 2-week and/or 3-week DMN treated rat livers compared to control rat liver. Acidic sphingomyelinase and alkaline ceramidase activities were significantly increased in 3-week DMN-treated rat kidneys compared to control rat kidney. Therefore, sphingolipid metabolizing enzymes and sphingolipid metabolites are supposed to be involved in liver fibrosis, although further investigation is necessary to elucidate meanings of sphingolipids during the liver fibrosis
Dimethylnitrosamine; Hepatic fibrosis; sphingomyelin cycle;
Citations & Related Records

Times Cited By Web Of Science : 1  (Related Records In Web of Science)
Times Cited By SCOPUS : 1
연도 인용수 순위
1 George, J. and Chandrakasan, G. (1996). Molecular characteristics of dimethylnitrosamine induced fibrotic liver collagen. Biochim Biophys Acta 1292, 215-222   DOI   ScienceOn
2 Jezequel, A. M., Mancini, R., Rinaldesi, M. L., Ballardini, G., Fallani, M., Bianchi, F. and Orlandi, F. (1989). Dimethylnitrosamine- induced cirrhosis. Evidence for an immunological mechanism. J Hepatol 8, 42-52   DOI   ScienceOn
3 Kim, Y., Ratziu, V., Choi, S. G., Lalazar, A., Theiss, G., Dang, Q., Kim, S. J. and Friedman, S. L. (1998). Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9/core promoter- binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. J Biol Chem 273, 33750-33758   DOI   ScienceOn
4 Kolesnick, R. (2002). The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J Clin Invest 110, 3-8   DOI
5 Lee, M. H., Yoon, S. and Moon, J. O. (2004). The flavonoid naringenin inhibits dimethylnitrosamine-induced liver damage in rats. Biol Pharm Bull 27, 72-76   DOI   ScienceOn
6 Chun, Y. J., Park, S. and Yang, S. A. (2003). Activation of Fas receptor modulates cytochrome P450 3A4 expression in human colon carcinoma cells. Toxicol Lett 146, 75-81   DOI   ScienceOn
7 Cock, J. G., Tepper, A. D., de Vries, E., van Blitterswijk, W. J. and Borst, J. (1998). CD95 (Fas/APO-1) induces ceramide formation and apoptosis in the absence of a functional acid sphingomyelinase. J Biol Chem 273, 7560- 7565   DOI   ScienceOn
8 Cuvillier, O. and Levade, T. (2003). Enzymes of sphingosine metabolism as potential pharmacological targets for therapeutic intervention in cancer. Pharmacol Res 47, 439-445   DOI   ScienceOn
9 Friedman, S. L. (1993). Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 328, 1828-1835   DOI   ScienceOn
10 Paolucci, F., Mancini, R., Marucci, L., Benedetti, A., Jezequel, A. M. and Orlandi, F. (1990). Immunohistochemical identification of proliferating cells following dimethylnitrosamine- induced liver injury. Liver 10, 278-281
11 Roberts, R. A., Ganey, P. E., Ju, C., Kamendulis, L. M., Rusyn, I. and Klaunig, J. E. (2007). Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol Sci 96, 2-15   DOI   ScienceOn
12 Shiba, M., Shimizu, I., Yasuda, M., Ii, K. and Ito, S. (1998). Expression of type I and type III collagens during the course of dimethylnitrosamine-induced hepatic fibrosis in rats. Liver 18, 196-204
13 Igarashi, Y. and Hakomori, S. (1989). Enzymatic synthesis of N,N-dimethyl-sphingosine: demonstration of the sphingosine: N-methyltransferase in mouse brain. Biochem Biophys Res Commun 164, 1411-1416   DOI   ScienceOn
14 Iredale, J. P. (2007). Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117, 539-548   DOI   ScienceOn
15 Jenkins, S. A., Grandison, A., Baxter, J. N., Day, D. W., Taylor, I. and Shields, R. (1985). A dimethylnitrosamineinduced model of cirrhosis and portal hypertension in the rat. J Hepatol 1, 489-499   DOI
16 Jezequel, A. M., Mancini, R., Rinaldesi, M. L., Macarri, G., Venturini, C. and Orlandi, F. (1987). A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat. J Hepatol 5, 174-181   DOI
17 Mathias, S., Pena, L. A. and Kolesnick, R. N. (1998). Signal transduction of stress via ceramide. Biochem J 335 (Pt 3), 465-480
18 Li, D. and Friedman, S. L. (1999). Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J Gastroenterol Hepatol 14, 618-633   DOI   ScienceOn
19 Liu, B. and Hannun, Y. A. (2000). Sphingomyelinase assay using radiolabeled substrate. Methods Enzymol 311, 164-167   DOI
20 Mancini, R., Jezequel, A. M., Benedetti, A., Paolucci, F., Trozzi, L. and Orlandi, F. (1992). Quantitative analysis of proliferating sinusoidal cells in dimethylnitrosamineinduced cirrhosis. An immunohistochemical study. J Hepatol 15, 361-366   DOI
21 Nikolova-Karakashian, M. and Merrill, A. H., Jr. (2000). Ceramidases. Methods Enzymol 311, 194-201   DOI
22 Obeid, L. M. and Hannun, Y. A. (2003). Ceramide, stress, and a 'LAG' in aging. Sci Aging Knowledge Environ 2003, PE27
23 Chalfant, C. E., Rathman, K., Pinkerman, R. L., Wood, R. E., Obeid, L. M., Ogretmen, B. and Hannun, Y. A. (2002). De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. J Biol Chem 277, 12587-12595   DOI   ScienceOn
24 Chen, J., Nikolova-Karakashian, M., Merrill, A. H., Jr. and Morgan, E. T. (1995). Regulation of cytochrome P450 2C11 (CYP2C11) gene expression by interleukin-1, sphingomyelin hydrolysis, and ceramides in rat hepatocytes. J Biol Chem 270, 25233-25238   DOI   ScienceOn
25 George, J., Rao, K. R., Stern, R. and Chandrakasan, G. (2001). Dimethylnitrosamine-induced liver injury in rats: the early deposition of collagen. Toxicology 156, 129- 138   DOI   ScienceOn
26 Haggerty, H. G. and Holsapple, M. P. (1990). Role of metabolism in dimethylnitrosamine-induced immunosuppression: a review. Toxicology 63, 1-23   DOI   ScienceOn
27 Hannun, Y. A. (1996). Functions of ceramide in coordinating cellular responses to stress. Science 274, 1855- 1859   DOI   ScienceOn
28 Hannun, Y. A., Luberto, C. and Argraves, K. M. (2001). Enzymes of sphingolipid metabolism: from modular to integrative signaling. Biochemistry 40, 4893-4903   DOI   ScienceOn
29 Hashimoto, N., Ishikawa, Y. and Utsunomiya, J. (1989). Effects of portacaval shunt, transposition, and dimethylnitrosamine- induced chronic liver injury on pancreatic hormones and amino acids in dog. J Surg Res 46, 35-40   DOI   ScienceOn